Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Cancer
 More »

  • RuiYi Licenses mAb Development to China's Genor
    most populous nation as a treatment for cancer and autoimmune diseases-especially ... widely implicated in inflammation and cancer. "The clinical data on IL-6 modulation ...
    5-16-2013
  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    treatment for metastatic colorectal cancer, Amgen today said it has identified ... KRAS exon 2 metastatic colorectal cancer treated with the Vectibix-FOLFOX combination. ...
    5-16-2013
  • Bayer Prostate Cancer Drug Gains FDA Approval
    market their advanced prostate cancer drug Xofigo® (radium Ra 223 dichloride) following approval yesterday by FDA. The second new prostate cancer treatment approved by FDA in ...
    5-16-2013
  • Improving Proteomics Approaches
    ... interactions have emerged as central in events downstream from DNA damage, such as cancer. ... in several diseases, including cardiovascular, neurodegenerative diseases, and cancer. ...
    5-15-2013
  • Seasoned Drugs Offer Therapeutic Gold Mine
    ... Research Institute, and director of the NCI Center for Modeling Cancer Development. Dr. ... two drugs for new roles against cancer: sunitinib (previously used for ...
    5-15-2013
  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    diagnostic for erlotinib (Tarceva), the cancer drug it also approved for the first-line treatment of metastatic non-small cell lung cancer (NSCLC) patients whose tumors show EFGR ...
    5-15-2013
  • Mass Spec Provides Peek into PTMs
    ... surface glycan changes that occur with cancer progression and other diseases, while ... tissues, with emphasis on human prostate cancer, renal cancer, and different therapeutic ...
    5-15-2013
  • Softening the Blow from FOLFOX Treatment
    into a drug candidate for colorectal cancer patients undergoing chemotherapy. ... caused by the chemo agent FOLFOX in patients treated for metastatic colorectal cancer. ...
    5-15-2013
  • Highlights from AACR
    At the 2013 AACR meeting, Stand Up to Cancer (SU2C) formally introduced its alliance with ... The Dream Team will receive a $14.5 million translational cancer research grant over four ...
    5-15-2013
  • Advertorial: Determining the Antioxidant Capacity of Beverages
    However, excess intracellular levels of ROS may result in cell and tissue damage and are therefore associated with degenerative diseases, most notably cancer. In healthy ...
    5-15-2013
  • Sorrento, Igdrasol Secure Exclusive E.U. Distribution Rights...
    Cynviloq is already approved and marketed in several countries for indications including metastatic breast cancer, non-small-cell lung cancer, and ovarian cancer. Sorrento and ...
    5-14-2013
  • RuiYi, CMC Collaborate to Speed mAb Development
    is highly selective to IL-6, a cytokine widely implicated in inflammation and cancer. ... designed to fight inflammation and cancer RuiYi, CMC Collaborate to Speed mAb ...
    5-14-2013
  • Mirna Initiates PI Trial for miRNA Candidate Cancer Drug
    Therapeutics today said it has initiated a Phase I clinical trial for its microRNA-based cancer candidate MRX34, making it the first miRNA to advance into such study for cancer. ...
    5-13-2013
  • Lilly Halts Development of Lymphoma Drug After Phase III Failure
    ... Those two Phase III molecules are necitumumab, indicated for squamous non-small cell lung cancer; and ramucirumab for breast cancer, colorectal cancer, and gastric cancer. Lilly ...
    5-10-2013
  • Amgen Forms Joint Venture to Sell Vectibix in China
    Amgen's metastatic colorectal cancer drug (mCRC) Vectibix® (panitumumab) in China. ... on developing and commercializing molecular targeted cancer drugs for Chinese patients. ...
    5-10-2013
  • More »

    Journal Articles

  • Antihypertensive Treatment, High Triglycerides, and Low High...
    Poul Suadicani, Hans Ole Hein, Finn Gyntelberg
    Metabolic Syndrome and Related Disorders
    and total cholesterol, glucosuria, electrocardiogram (ECG) changes, cancer history, body mass index, alcohol and tobacco use, leisure time physical activity, social class, and age. ...
  • International Telepharmacy Education: Another Venue to Improve...
    William L. Greene, Yuri Quintana, Raul C. Ribeiro, Ibrahim A. Qaddoumi, Ahmad S. AlFaar, Sherif Kamal, Sherif AbouElnaga
    Telemedicine and e-Health
    Improve Cancer Care in the Developing World Telemedicine and e-Health Objective: In developed countries, pharmacists play a crucial role in designing and implementing cancer ...
  • Nonexpanded Mesenchymal Stem Cells for Regenerative Medicine...
    Massimo Faustini, Massimo Bucco, Theodora Chlapanidas, Giulia Lucconi, Mario Marazzi, Marta Cecilia Tosca, Paolo Gaetani, Marco Klinger, Simona Villani, Virginia Valeria Ferretti, Daniele Vigo, Maria Luisa Torre
    Tissue Engineering, Part C: Methods
    These cells are ideal candidates for use in regenerative medicine, tissue engineering, including gene therapy, and cell replacement cancer therapies. In this work, we aimed to the ...
  • Process-Induced Cell Injury in Laser Direct Writing of Human...
    Yafu Lin, Guohui Huang, Yong Huang, Tzuen-Rong J. Tzeng, Douglas B. Chrisey
    Tissue Engineering, Part C: Methods
    Process-Induced Cell Injury in Laser Direct Writing of Human Colon Cancer Cells Tissue ... post-transfer cell viability in laser direct writing of human colon cancer HT-29 cells. ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll